EFAI
About EFAI
Ever Fortune.AI (EFAI) is a healthcare AI company that develops advanced technology to improve medical workflows and patient outcomes across various specialties. Their solutions are designed to assist physicians in interpreting medical images and providing objective information, aiming to reduce diagnostic time and costs, and allow more time for patient communication. EFAI’s product catalog includes AI-enabled medical software for image viewing and analysis, workflow management, remote access, reporting, and clinical notification workflows. They offer systems for chest X-ray interpretation, acute aortic syndrome detection, radiotherapy organ segmentation, bone scintigraphy computer-assisted detection, intracerebral hemorrhage detection, myocardial perfusion reporting, bone age assessment, STEMI detection, ECG analysis, and PACS. Many of their products have received regulatory clearances from both Taiwan’s TFDA and the U.S. FDA.
EFAI’s technology leverages natural language processing (NLP), convolutional neural networks (CNN), and recurrent neural networks (RNN). The company’s mission is to drive continuous innovation in big data and artificial intelligence within intelligent and precision medicine. They are actively expanding their presence in international markets, including ASEAN countries, Europe, and the United States, through strategic partnerships and distribution agreements. EFAI also focuses on developing AI adaptive radiotherapy platforms, which utilize real-time data analysis to dynamically adjust treatment plans, enhancing precision and minimizing side effects in cancer treatment.
Focus Areas
Business Intelligence
| Technology | AI-enabled medical software for image viewing and analysis, workflow management, remote access, reporting, and clinical notification workflows. Utilizes deep learning algorithms, natural language processing (NLP), convolutional neural networks (CNN), and recurrent neural networks (RNN). |
What Physicians Need to Know
EFAI's AI solutions act as a 'clinical co-pilot' to assist physicians, rather than replacing their diagnosis. These tools are designed to prioritize high-risk cases, accelerate image review, and streamline administrative tasks, allowing physicians to focus on complex clinical decisions and patient interpretation. The systems provide real-time recognition and notifications for critical findings, aiming to reduce diagnostic variation and improve patient outcomes through faster diagnosis and intervention.
EFAI's AI software is designed for seamless integration into existing clinical environments. Their radiotherapy solutions, AutoSeg and AdaptInsight, connect directly to popular treatment planning systems like Eclipse, RayStation, Monaco, and Pinnacle via DICOM. Their diagnostic systems often integrate with PACS/RIS workstations for worklist prioritization and notifications. The bone age interpretation software can be customized to integrate with existing PACS systems in hospitals.
What the Web Says
EverFortune.AI (EFAI) is a company specializing in AI-driven medical solutions, particularly in the healthcare IT sector. They have developed various clinical-grade medical AI products, including systems for lung CAD, pediatric growth assessment, intelligent health check scheduling, and adaptive radiotherapy. The company has shown significant growth, with a reported 312% year-on-year revenue increase in the first 11 months of 2024. EFAI has also secured numerous medical device certifications from Taiwan's TFDA and the U.S. FDA for a wide range of applications.
Overall: MixedStrengths
- Clinical-grade medical AI products with multiple certifications (FDA, TFDA).
- Offers solutions for various medical fields, including radiology, pediatrics, and oncology.
- Demonstrated robust operational growth and revenue increase.
- Products aim to reduce patient waiting times and improve efficiency in healthcare.
- Focus on personalized and precision cancer treatment through AI adaptive radiotherapy.
- Systems can integrate with existing PACS systems in hospitals.
Limitations
- No specific product or employer reviews were found on G2, Glassdoor, Capterra, or Reddit directly for "EFAI" or "Everfortune.ai".
- Some features of their products are still under review or available as "Research Features".
- One Reddit thread mentions a company called "EVERAI" with fraudulent charges, but it is unclear if this is related to Everfortune.ai.
- General AI patient engagement software can be difficult for some users to grasp.
- No public pricing or API information for some related AI visibility products.
Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT reviewers, Reddit
Last updated: 2026-10-23
Videos
News, demos, and interviews about EFAI.
Videos load interactively. If none appear, search YouTube for EFAI →
Press & Coverage
Frequently Asked Questions
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]